HR Execs on the Move

Accolade

www.accolade.com

 
We`re the only on-demand healthcare concierge for employers, health plans and health systems. Join our customers who experience industry-leading engagement levels, satisfaction scores unseen in health care, better health outcomes, and substantial medical cost savings of more than 10 percent. Our team of compassionate, trusted professionals, supported by breakthrough science and technologies guide consumers through the healthcare system in a deeply personalized manner. We`ve been recognized as one of the nation`s 25 most promising companies by Forbes magazine, the fastest-growing private healthcare company by Inc. 500, and a top workplace by multiple news publications.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.accolade.com
  • 660 West Germantown Pike Suite 500
    Plymouth Meeting, PA USA 19462
  • Phone: 610.834.2989

Executives

Name Title Contact Details
Brooke Strode
VP, Business Development and Strategic Growth- Health Plan Profile
Emily Ford
Senior Director, HR Business Partner Profile
Tricia Schmidt
Senior Director, Enterprise Sales Leader Profile
Andrew Rosa
Vice President Customer Care Profile
Eve Stacey
Chief Customer Officer Profile

Similar Companies

The Hearing And Speech Agency Of Metropolitan Baltimore Inc

The Hearing And Speech Agency Of Metropolitan Baltimore Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Baltimore, MD. To find more information about The Hearing And Speech Agency Of Metropolitan Baltimore Inc, please visit www.hasa.org

Flugen

FluGen is driving the development of a universal flu vaccine to advance human health.

Ambry Genetics

Ambry Genetics is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

U.S. HealthWorks

U.S. HealthWorks is a Valencia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nu-Med Plus

Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to concentrate on high growth potential markets where there are visible, distinct needs recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of nitric oxide gas for therapeutic use.